Drug used in glaucoma may boost tear duct surgery success
NCT ID NCT07154121
Summary
This study is testing if adding a drug called 5-Fluorouracil (5-FU) during a specific tear duct surgery makes it more successful. It focuses on adults with a blocked tear duct and a particularly small tear sac, which makes standard surgery less effective. Researchers will compare surgery with the drug to surgery alone to see if it reduces scar tissue and keeps the new drainage opening clear.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY ACQUIRED NASOLACRIMAL DUCT OBSTRUCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongshan Ophthalmic Center
RECRUITINGGuangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.